RxSight, Inc(NASDAQ:RXST) 
RxSight, Inc., a medical technology company, develops light adjustable lens (LAL) to improve uncorrected visual acuity that can be adjusted enhance uncorrected visual acuity after cataract surgery. It also offers RxSight light delivery device, an office-based light treatment device that delivers UV ...
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
sales | 30,893,000 | 32,608,000 | 30,340,000 | 33,637,000 | 37,895,000 | 40,214,000 | 35,314,000 | 34,887,000 | 29,512,000 | 28,580,000 | 22,199,000 | 20,810,000 | 17,489,000 | 16,088,000 | 12,615,000 | 11,360,000 | 8,942,000 | 8,426,000 | 5,786,000 | 4,897,000 |
cost of sales | 7,395,000 | 7,345,000 | 6,113,000 | 8,447,000 | 9,566,000 | 11,426,000 | 10,094,000 | 10,637,000 | 8,827,000 | 10,926,000 | 8,468,000 | 8,795,000 | 7,123,000 | 8,666,000 | 7,259,000 | 6,572,000 | 5,181,000 | 5,557,000 | 4,445,000 | 5,709,000 |
gross profit | 23,498,000 | 25,263,000 | 24,227,000 | 25,190,000 | 28,329,000 | 28,788,000 | 25,220,000 | 24,250,000 | 20,685,000 | 17,654,000 | 13,731,000 | 12,015,000 | 10,366,000 | 7,422,000 | 5,356,000 | 4,788,000 | 3,761,000 | 2,869,000 | 1,341,000 | -812,000 |
yoy | -17.05% | -12.24% | -3.94% | 3.88% | 36.95% | 63.07% | 83.67% | 101.83% | 99.55% | 137.86% | 156.37% | 150.94% | 175.62% | 158.70% | 299.40% | -689.66% | ||||
qoq | -6.99% | 4.28% | -3.82% | -11.08% | -1.59% | 14.15% | 4.00% | 17.23% | 17.17% | 28.57% | 14.28% | 15.91% | 39.67% | 38.57% | 11.86% | 27.31% | 31.09% | 113.94% | -265.15% | |
operating expenses: | ||||||||||||||||||||
selling, general and administrative | 31,855,000 | 27,695,000 | 27,345,000 | 28,976,000 | 28,636,000 | 28,209,000 | 25,608,000 | 24,292,000 | 23,324,000 | 21,165,000 | 19,142,000 | 18,239,000 | 16,255,000 | 15,731,000 | 14,926,000 | 14,388,000 | 13,620,000 | 11,616,000 | 9,076,000 | 6,502,000 |
research and development | 9,472,000 | 8,905,000 | 9,060,000 | 10,217,000 | 10,367,000 | 9,207,000 | 8,838,000 | 8,291,000 | 8,031,000 | 7,341,000 | 7,101,000 | 7,401,000 | 7,208,000 | 6,681,000 | 6,388,000 | 6,192,000 | 6,719,000 | 5,916,000 | 5,377,000 | 6,563,000 |
total operating expenses | 41,327,000 | 36,600,000 | 36,405,000 | 39,193,000 | 39,003,000 | 37,416,000 | 34,446,000 | 32,583,000 | 31,355,000 | 28,506,000 | 26,243,000 | 25,640,000 | 23,463,000 | 22,412,000 | 21,314,000 | 20,580,000 | 20,339,000 | 17,532,000 | 14,453,000 | 13,065,000 |
income from operations | -17,829,000 | -11,337,000 | -12,178,000 | -14,003,000 | -10,674,000 | -8,628,000 | -9,226,000 | -8,333,000 | -10,670,000 | -10,852,000 | -12,512,000 | -13,625,000 | -13,097,000 | -14,990,000 | -15,958,000 | -15,792,000 | -16,578,000 | -14,663,000 | -13,112,000 | -13,877,000 |
yoy | 67.03% | 31.40% | 32.00% | 68.04% | 0.04% | -20.49% | -26.26% | -38.84% | -18.53% | -27.61% | -21.59% | -13.72% | -21.00% | 2.23% | 21.71% | 13.80% | ||||
qoq | 57.26% | -6.91% | -13.03% | 31.19% | 23.71% | -6.48% | 10.72% | -21.90% | -1.68% | -13.27% | -8.17% | 4.03% | -12.63% | -6.07% | 1.05% | -4.74% | 13.06% | 11.83% | -5.51% | |
other income, net: | ||||||||||||||||||||
interest expense | -3,000 | -5,000 | -4,000 | -5,000 | -6,000 | -5,000 | -5,000 | -6,000 | -6,000 | -4,000 | -230,000 | -1,568,000 | -1,507,000 | -1,451,000 | -1,299,000 | -1,136,000 | -1,060,000 | -1,079,000 | -1,079,000 | -826,000 |
interest and other income | 1,954,000 | 2,195,000 | 2,376,000 | 2,254,000 | 2,508,000 | 2,707,000 | 2,906,000 | 2,276,000 | 1,585,000 | 1,661,000 | 1,746,000 | 1,777,000 | 1,392,000 | 836,000 | 439,000 | 196,000 | 46,000 | 10,000 | 11,000 | 15,000 |
income before income taxes | -15,878,000 | -9,147,000 | -9,806,000 | -11,754,000 | -8,172,000 | -5,926,000 | -6,325,000 | -6,063,000 | -9,091,000 | -9,195,000 | -12,403,000 | -13,778,000 | -13,212,000 | -15,605,000 | -16,818,000 | -16,732,000 | -17,592,000 | -15,732,000 | -12,677,000 | -13,474,000 |
income tax expense | 6,000 | 5,000 | 10,000 | 32,000 | 18,000 | 12,000 | 13,000 | 16,000 | 9,000 | -18,000 | 12,000 | 26,000 | 5,000 | 4,000 | 2,000 | -4,000 | 3,000 | |||
net income | -15,884,000 | -9,152,000 | -9,816,000 | -11,786,000 | -8,190,000 | -5,938,000 | -6,338,000 | -6,079,000 | -9,100,000 | -9,177,000 | -12,415,000 | -13,804,000 | -13,212,000 | -15,610,000 | -16,818,000 | -16,732,000 | -17,596,000 | -15,734,000 | -12,673,000 | -13,477,000 |
yoy | 93.94% | 54.13% | 54.88% | 93.88% | -10.00% | -35.29% | -48.95% | -55.96% | -31.12% | -41.21% | -26.18% | -17.50% | -24.91% | -0.79% | 32.71% | 24.15% | ||||
qoq | 73.56% | -6.76% | -16.71% | 43.91% | 37.93% | -6.31% | 4.26% | -33.20% | -0.84% | -26.08% | -10.06% | 4.48% | -15.36% | -7.18% | 0.51% | -4.91% | 11.83% | 24.15% | -5.97% | |
other comprehensive loss | ||||||||||||||||||||
unrealized loss on short-term investments | -120,000 | -146,000 | -157,000 | -5,000 | -5,000 | |||||||||||||||
foreign currency translation gain | 5,000 | -1,000 | 14,000 | 6,000 | -11,000 | 6,000 | -1,000 | -3,000 | 1,000 | 2,000 | -9,000 | 1,000 | ||||||||
total other comprehensive loss | -120,000 | -26,250 | 177,000 | -132,000 | -151,000 | -85,000 | -9,000 | -8,000 | -3,000 | |||||||||||
comprehensive loss | -16,004,000 | -9,160,000 | -9,639,000 | -11,918,000 | -8,341,000 | -6,293,000 | -5,699,000 | -6,144,000 | -9,148,000 | -9,122,000 | -12,402,000 | -13,868,000 | -13,126,000 | -15,567,000 | -16,773,000 | -16,817,000 | -17,674,000 | -13,480,000 | ||
net income per share | ||||||||||||||||||||
basic & diluted | -0.38 | -0.183 | -0.24 | -0.29 | -0.2 | -0.14 | -0.16 | -0.16 | -0.25 | -0.25 | -0.35 | -0.4 | -0.42 | |||||||
weighted-average shares used for eps calculation | ||||||||||||||||||||
attributable to common stock, basic & diluted | 41,306,110 | 10,185,304.75 | 40,965,219 | 40,743,786 | 40,509,646 | 9,591,939.75 | 39,788,621 | 38,455,955 | 36,843,087 | 507,780 | 35,662,397 | 34,498,265 | 31,637,097 | -0.55 | -0.61 | |||||
unrealized gain on short-term investments | -13,000 | 178,000 | -344,000 | 633,000 | -64,000 | -45,000 | 45,000 | 19,000 | -65,000 | 84,000 | -23,750 | 55,000 | -76,000 | -4,000 | ||||||
loss on extinguishment of term loan | -1,407,000 | -362,000 | ||||||||||||||||||
other comprehensive income | ||||||||||||||||||||
total other comprehensive income | -355,000 | 639,000 | -65,000 | -48,000 | 55,000 | 13,000 | -64,000 | 86,000 | -29,500 | 45,000 | -78,000 | |||||||||
foreign currency translation | -750 | -6,000 | ||||||||||||||||||
change in fair value of warrants | 1,503,000 | 1,214,000 | ||||||||||||||||||
expiration of warrant | ||||||||||||||||||||
foreign currency translation loss | 14,000 | -10,000 | -4,000 | -4,000 | -3,000 | |||||||||||||||
attributable to series g common stock, basic and diluted | -0.32 | |||||||||||||||||||
attributable to common stock, basic | -0.61 | 0.09 | -0.68 | -3.28 | ||||||||||||||||
attributable to common stock, diluted | -0.61 | 0.09 | -0.68 | -3.53 | ||||||||||||||||
unrealized income on short-term investments | -74,000 | |||||||||||||||||||
attributable to common stock, basic and diluted | -0.64 | |||||||||||||||||||
accretion to redemption value of redeemable preferred stock and redeemable stock options | ||||||||||||||||||||
earnings allocated to redeemable preferred stock | ||||||||||||||||||||
net income attributable to common stockholders | -15,734,000 | -12,673,000 | ||||||||||||||||||
comprehensive income | -8,240,500 | -12,681,000 | ||||||||||||||||||
attributable to redeemable common stock, basic | ||||||||||||||||||||
attributable to redeemable common stock, diluted | ||||||||||||||||||||
net loss attributable to common stockholders | -13,477,000 | |||||||||||||||||||
attributable to redeemable common stock, basic and diluted |
Balance Sheets:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | ||||||||||||||||||||
current assets: | ||||||||||||||||||||
cash and cash equivalents | 17,573,000 | 19,949,000 | 29,633,000 | 40,355,000 | 28,000,000 | 16,706,000 | 16,720,000 | 24,445,000 | 32,645,000 | 9,692,000 | 9,859,000 | 8,753,000 | 11,012,000 | 11,834,000 | 8,912,000 | 24,004,000 | 24,132,000 | 24,361,000 | 68,278,000 | 41,731,000 |
short-term investments | 200,307,000 | 208,179,000 | 197,883,000 | 187,136,000 | 201,341,000 | 220,517,000 | 220,400,000 | 208,839,000 | 92,709,000 | 117,490,000 | 122,023,000 | 138,340,000 | 142,927,000 | 93,968,000 | 103,923,000 | 104,616,000 | 119,715,000 | 134,971,000 | 99,985,000 | 19,998,000 |
accounts receivable | 22,443,000 | 23,383,000 | 24,151,000 | 28,058,000 | 30,958,000 | 30,050,000 | 25,368,000 | 25,723,000 | 21,550,000 | 20,281,000 | 15,244,000 | 13,295,000 | 12,668,000 | 10,956,000 | 9,020,000 | 6,884,000 | 5,626,000 | 4,862,000 | 4,357,000 | 3,936,000 |
inventories | 34,869,000 | 31,559,000 | 28,950,000 | 25,061,000 | 23,574,000 | 22,009,000 | 21,673,000 | 19,443,000 | 18,700,000 | 17,421,000 | 18,924,000 | 17,945,000 | 18,067,000 | 14,835,000 | 15,336,000 | 11,622,000 | 8,490,000 | 8,032,000 | 9,442,000 | 8,543,000 |
prepaid and other current assets | 4,033,000 | 4,389,000 | 3,260,000 | 3,264,000 | 4,541,000 | 4,541,000 | 2,607,000 | 2,773,000 | 2,955,000 | 3,523,000 | 1,897,000 | 2,112,000 | 2,992,000 | 2,962,000 | 1,971,000 | 2,802,000 | 3,184,000 | 4,069,000 | 4,274,000 | 1,338,000 |
total current assets | 279,225,000 | 287,459,000 | 283,877,000 | 283,874,000 | 288,414,000 | 293,823,000 | 286,768,000 | 281,223,000 | 168,559,000 | 168,407,000 | 167,947,000 | 180,445,000 | 187,666,000 | 134,555,000 | 139,162,000 | 149,928,000 | 161,147,000 | 176,295,000 | 186,336,000 | 75,546,000 |
property and equipment | 13,232,000 | 13,056,000 | 13,096,000 | 13,255,000 | 12,557,000 | 12,413,000 | 12,241,000 | 12,444,000 | 11,617,000 | 10,841,000 | 10,262,000 | 10,533,000 | 9,804,000 | 10,138,000 | 10,620,000 | 11,083,000 | 10,915,000 | 11,217,000 | 11,991,000 | 12,686,000 |
operating leases right-of-use assets | 9,760,000 | 9,959,000 | 10,276,000 | 10,588,000 | 10,922,000 | 11,217,000 | 10,536,000 | 10,818,000 | 2,052,000 | 2,444,000 | 2,793,000 | 3,174,000 | 3,555,000 | 3,943,000 | 4,331,000 | 4,704,000 | 4,057,000 | 4,284,000 | 4,561,000 | 4,749,000 |
restricted cash | 750,000 | 750,000 | 748,000 | 750,000 | 750,000 | 750,000 | 711,000 | 711,000 | 711,000 | 711,000 | 711,000 | 761,000 | 761,000 | 761,000 | 811,000 | 811,000 | 811,000 | 811,000 | 561,000 | 561,000 |
other assets | 1,026,000 | 590,000 | 536,000 | 542,000 | 401,000 | 360,000 | 213,000 | 303,000 | 226,000 | 147,000 | 137,000 | 348,000 | 746,000 | 767,000 | 782,000 | 188,000 | 132,000 | 114,000 | 287,000 | 1,344,000 |
total assets | 303,993,000 | 311,814,000 | 308,533,000 | 309,009,000 | 313,044,000 | 318,563,000 | 310,469,000 | 305,499,000 | 183,165,000 | 182,550,000 | 181,850,000 | 195,261,000 | 202,532,000 | 150,164,000 | 155,706,000 | 166,714,000 | 177,062,000 | 192,721,000 | 203,736,000 | 94,886,000 |
liabilities and stockholders' equity | ||||||||||||||||||||
current liabilities: | ||||||||||||||||||||
accounts payable | 7,124,000 | 5,296,000 | 3,377,000 | 3,348,000 | 7,111,000 | 4,544,000 | 4,581,000 | 5,095,000 | 5,057,000 | 3,863,000 | 4,105,000 | 3,997,000 | 3,717,000 | 2,595,000 | 4,172,000 | 3,277,000 | 2,587,000 | 1,689,000 | 1,691,000 | 2,342,000 |
accrued expenses and other current liabilities | 18,748,000 | 19,795,000 | 17,621,000 | 15,934,000 | 14,575,000 | 20,358,000 | 17,323,000 | 13,787,000 | 11,657,000 | 15,239,000 | 12,861,000 | 10,588,000 | 9,181,000 | 12,672,000 | 10,248,000 | 7,877,000 | 6,409,000 | 7,859,000 | 6,016,000 | 4,781,000 |
lease liabilities | 1,504,000 | 1,162,000 | 1,293,000 | 1,101,000 | 1,055,000 | 974,000 | 734,000 | 736,000 | 1,614,000 | 1,801,000 | 1,976,000 | 1,980,000 | 1,978,000 | 1,970,000 | 1,948,000 | 1,842,000 | 1,663,000 | 1,529,000 | 1,469,000 | 1,365,000 |
total current liabilities | 27,376,000 | 26,253,000 | 22,291,000 | 20,383,000 | 22,741,000 | 25,876,000 | 22,638,000 | 19,618,000 | 18,328,000 | 20,903,000 | 18,942,000 | 16,565,000 | 14,876,000 | 17,237,000 | 16,368,000 | 12,996,000 | 10,659,000 | 11,077,000 | 9,176,000 | 11,102,000 |
long-term lease liabilities | 9,322,000 | 9,878,000 | 10,272,000 | 10,614,000 | 10,987,000 | 11,322,000 | 10,570,000 | 10,674,000 | 908,000 | 1,211,000 | 1,354,000 | 1,843,000 | 2,338,000 | 2,856,000 | 3,354,000 | 3,851,000 | 3,350,000 | 3,642,000 | 4,033,000 | 4,374,000 |
total liabilities | 36,698,000 | 36,131,000 | 32,563,000 | 30,997,000 | 33,728,000 | 37,325,000 | 33,208,000 | 30,292,000 | 19,236,000 | 22,188,000 | 20,371,000 | 38,073,000 | 57,523,000 | 60,262,000 | 59,747,000 | 56,728,000 | 53,899,000 | 54,479,000 | 52,845,000 | 54,982,000 |
commitments and contingencies | ||||||||||||||||||||
stockholders' equity: | ||||||||||||||||||||
common stock, 0.001 par value... | 41,000 | 41,000 | 41,000 | 41,000 | 41,000 | 40,000 | 40,000 | 40,000 | 37,000 | 36,000 | 36,000 | 35,000 | 34,000 | 28,000 | 28,000 | 27,000 | 27,000 | |||
preferred stock, 0.001 par value... | 353,300,000 | |||||||||||||||||||
additional paid-in capital | 944,244,000 | 936,628,000 | 927,756,000 | 920,159,000 | 909,545,000 | 903,127,000 | 892,857,000 | 885,104,000 | 767,685,000 | 754,971,000 | 746,966,000 | 730,274,000 | 704,228,000 | 636,001,000 | 626,491,000 | 623,746,000 | 620,106,000 | 617,511,000 | 614,418,000 | 137,838,000 |
accumulated other comprehensive income | -67,000 | 60,000 | -117,000 | 15,000 | 521,000 | |||||||||||||||
accumulated deficit | -676,923,000 | -661,039,000 | -651,887,000 | -642,071,000 | -630,285,000 | -622,095,000 | -616,157,000 | -609,819,000 | -603,740,000 | -594,640,000 | -585,463,000 | -573,048,000 | -559,244,000 | -546,032,000 | -530,422,000 | -513,604,000 | -496,872,000 | -479,276,000 | -463,543,000 | -450,870,000 |
total stockholders' equity | 267,295,000 | 275,683,000 | 275,970,000 | 278,012,000 | 279,316,000 | 281,238,000 | 277,261,000 | 275,207,000 | 163,929,000 | 160,362,000 | 161,479,000 | 157,188,000 | 145,009,000 | 89,902,000 | 95,959,000 | 109,986,000 | 123,163,000 | 138,242,000 | 150,891,000 | |
total liabilities and stockholders' equity | 303,993,000 | 311,814,000 | 308,533,000 | 309,009,000 | 313,044,000 | 318,563,000 | 310,469,000 | 305,499,000 | 183,165,000 | 182,550,000 | 181,850,000 | 195,261,000 | 202,532,000 | 150,164,000 | 155,706,000 | 166,714,000 | 177,062,000 | |||
other long-term liabilities | 127,000 | 74,000 | 75,000 | 76,000 | ||||||||||||||||
accumulated other comprehensive loss | 53,000 | 166,000 | -118,000 | -53,000 | -5,000 | -60,000 | -73,000 | -9,000 | -95,000 | -138,000 | -183,000 | -98,000 | -20,000 | -11,000 | -3,000 | |||||
term loan | 19,589,000 | 40,309,000 | 40,169,000 | 40,025,000 | 39,881,000 | 39,890,000 | 39,760,000 | 39,636,000 | 39,506,000 | |||||||||||
liabilities, redeemable common stock, stock options, convertible preferred stock and stockholders' equity | ||||||||||||||||||||
warrant liability | 2,614,000 | |||||||||||||||||||
long-term warrant liability | ||||||||||||||||||||
redeemable common stock: | ||||||||||||||||||||
notes receivable for common stock issued | ||||||||||||||||||||
redeemable stock options | ||||||||||||||||||||
convertible preferred stock: | ||||||||||||||||||||
stockholders' equity | ||||||||||||||||||||
series g common stock, 0.001 par value... | ||||||||||||||||||||
series w common stock, 0.001 par value... | ||||||||||||||||||||
total liabilities, redeemable common stock, stock options, convertible preferred stock and stockholders' equity | 192,721,000 | 203,736,000 | ||||||||||||||||||
stockholders' deficit: | ||||||||||||||||||||
the balance sheet at december 31,2020 has been derived from the audited consolidated financial statements included in rxsight, inc.'s final prospectus for its public offering filed on july 29, 2021. | ||||||||||||||||||||
liabilities, redeemable common stock, stock options, convertible preferred stock and stockholders' deficit | ||||||||||||||||||||
total stockholders' deficit | -313,396,000 | |||||||||||||||||||
total liabilities, redeemable common stock, stock options, convertible preferred stock and stockholders' deficit | 94,886,000 |
Cashflow Statements:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
operating activities: | |||||||||||||||||||
net loss | -15,884,000 | -9,152,000 | -9,816,000 | -11,786,000 | -8,190,000 | -5,938,000 | -6,338,000 | -6,079,000 | -9,100,000 | -9,177,000 | -12,415,000 | -13,804,000 | -13,212,000 | -15,610,000 | -16,818,000 | -16,732,000 | -17,596,000 | ||
adjustments to reconcile net loss to net cash from operating activities: | |||||||||||||||||||
depreciation and amortization | 834,000 | 851,000 | 854,000 | 785,000 | 776,000 | 515,000 | 1,133,000 | 812,000 | 1,115,000 | 1,051,000 | 1,083,000 | 989,000 | 955,000 | 918,000 | 941,000 | 1,009,000 | 1,016,000 | 1,025,000 | 1,006,000 |
provision for bad debts | 0 | 0 | 11,000 | 21,000 | 0 | ||||||||||||||
amortization of right-of-use lease assets | 9,000 | 8,000 | 8,000 | 8,000 | 25,000 | 33,000 | 47,000 | 41,000 | 44,000 | 43,000 | 39,000 | 37,000 | 19,000 | -6,000 | 4,000 | ||||
amortization of discount on short-term investments | -1,854,000 | -1,832,000 | -2,144,000 | -2,130,000 | -2,411,000 | -2,628,000 | -2,771,000 | -2,073,000 | -1,505,000 | -1,577,000 | -1,592,000 | -1,696,000 | -1,257,000 | -783,000 | -391,000 | -184,000 | -47,000 | -11,000 | -4,000 |
stock-based compensation | 7,945,000 | 7,817,000 | 8,108,000 | 8,547,000 | 7,140,000 | 7,282,000 | 6,552,000 | 6,105,000 | 4,696,000 | 4,425,000 | 4,071,000 | 3,955,000 | 3,295,000 | 2,962,000 | 2,882,000 | 2,904,000 | 2,649,000 | 2,917,000 | 2,013,000 |
provision for excess and obsolete inventory | 60,000 | 616,000 | 66,000 | 1,219,000 | 31,000 | 71,000 | 166,000 | 56,000 | 111,000 | 151,000 | -1,000 | 4,000 | 10,000 | 298,000 | 334,000 | 47,000 | 73,000 | 10,000 | |
change in operating assets and liabilities: | |||||||||||||||||||
accounts receivable | 936,000 | 788,000 | 3,907,000 | 2,888,000 | -928,000 | -4,682,000 | 320,000 | -4,172,000 | -1,269,000 | -5,037,000 | -1,950,000 | -626,000 | -1,712,000 | -1,935,000 | -2,137,000 | -1,258,000 | -764,000 | -504,000 | -421,000 |
inventories | -3,370,000 | -3,225,000 | -3,955,000 | -2,705,000 | -1,597,000 | -408,000 | -2,396,000 | -799,000 | -1,390,000 | 1,352,000 | -977,000 | 117,000 | -3,241,000 | 203,000 | -4,048,000 | -3,180,000 | -530,000 | 1,400,000 | -1,507,000 |
prepaid and other assets | 120,000 | -881,000 | 322,000 | 1,488,000 | 254,000 | -2,080,000 | 177,000 | 104,000 | 569,000 | -1,559,000 | 129,000 | 1,328,000 | -460,000 | -824,000 | 514,000 | 285,000 | 814,000 | 346,000 | -1,905,000 |
accounts payable | 1,577,000 | 2,204,000 | -86,000 | -3,717,000 | 2,226,000 | 116,000 | 41,000 | -387,000 | 1,176,000 | -158,000 | 84,000 | 161,000 | 1,163,000 | -1,696,000 | 983,000 | 647,000 | 701,000 | 101,000 | -741,000 |
accrued expenses and other liabilities | -1,255,000 | 1,698,000 | 1,557,000 | 1,033,000 | -6,163,000 | 3,484,000 | 3,724,000 | 2,398,000 | -3,737,000 | 2,195,000 | 2,128,000 | 1,481,000 | -3,490,000 | 2,426,000 | 2,370,000 | 1,467,000 | -1,450,000 | 1,602,000 | 1,235,000 |
net cash from operating activities | -10,891,000 | -1,116,000 | -1,187,000 | -4,376,000 | -8,832,000 | -4,260,000 | 650,000 | -4,027,000 | -9,309,000 | -8,301,000 | -7,982,000 | -7,546,000 | -17,764,000 | -13,854,000 | -15,188,000 | -14,823,000 | -14,985,000 | -8,722,000 | -13,755,000 |
capital expenditures | -589,000 | 0 | -696,000 | -1,491,000 | -371,000 | -695,000 | -939,000 | -1,637,000 | -1,624,000 | -1,520,000 | -850,000 | -1,674,000 | -488,000 | -214,000 | -667,000 | -1,040,000 | -173,000 | -473,000 | -192,000 |
free cash flows | -11,480,000 | -1,116,000 | -1,883,000 | -5,867,000 | -9,203,000 | -4,955,000 | -289,000 | -5,664,000 | -10,933,000 | -9,821,000 | -8,832,000 | -9,220,000 | -18,252,000 | -14,068,000 | -15,855,000 | -15,863,000 | -15,158,000 | -9,195,000 | -13,947,000 |
investing activities: | |||||||||||||||||||
purchases of property and equipment | -759,000 | -581,000 | -1,537,000 | -575,000 | -365,000 | -254,000 | |||||||||||||
maturities of short-term investments | 110,000,000 | 60,000,000 | 50,000,000 | 60,000,000 | |||||||||||||||
purchases of short-term investments | -100,393,000 | -98,477,000 | -68,423,000 | -33,811,000 | -38,570,000 | -52,833,000 | -77,157,000 | -159,122,000 | -47,759,000 | -43,843,000 | -72,072,000 | -48,782,000 | -107,618,000 | -34,233,000 | -73,860,000 | -29,793,000 | -74,771,000 | ||
net cash from investing activities | 8,848,000 | -9,614,000 | -9,004,000 | 14,652,000 | 20,855,000 | 1,320,000 | -9,260,000 | 4,566,000 | 17,275,000 | 4,395,000 | -48,365,000 | 10,405,000 | 560,000 | 14,126,000 | 14,859,000 | -35,346,000 | -80,241,000 | ||
financing activities: | |||||||||||||||||||
proceeds from issuance of common stock | 144,000 | 1,056,000 | 131,000 | 2,068,000 | 696,000 | 2,988,000 | 3,835,000 | 3,840,000 | 10,153,000 | 3,583,000 | 1,994,000 | 145,000 | |||||||
payments for employee taxes related to stock compensation | -473,000 | -2,000 | -642,000 | 0 | -1,418,000 | 0 | -2,635,000 | 1,000 | -2,134,000 | -2,000 | -1,084,000 | 0 | -337,000 | 0 | -281,000 | 0 | -362,000 | ||
principal payments on finance lease liabilities | -7,000 | 9,000 | -19,000 | -3,000 | -13,000 | -12,000 | -11,000 | -11,000 | -27,000 | -34,000 | -37,000 | -41,000 | -41,000 | -39,000 | -22,000 | -16,000 | -44,000 | -6,000 | -5,000 |
net cash from financing activities | -336,000 | 1,063,000 | -530,000 | 2,065,000 | -735,000 | 2,976,000 | 878,000 | 111,473,000 | 7,992,000 | 3,562,000 | -8,234,000 | 891,000 | 65,305,000 | 6,307,000 | -455,000 | 578,000 | -98,000 | 404,000 | 120,547,000 |
effect of foreign exchange rate on cash, cash equivalents and restricted cash | 3,000 | -15,000 | -2,000 | 14,000 | 6,000 | -12,000 | 7,000 | -1,000 | -3,000 | 8,000 | -5,000 | 1,000 | 2,000 | 14,000 | -9,000 | -9,000 | -5,000 | -3,000 | -4,000 |
net increase in cash, cash equivalents and restricted cash | -2,376,000 | -9,683,000 | -10,723,000 | 12,355,000 | 11,294,000 | 24,000 | -7,725,000 | -8,200,000 | 22,954,000 | 2,872,000 | -15,092,000 | -128,000 | -229,000 | -43,667,000 | 26,547,000 | ||||
cash, cash equivalents and restricted cash - beginning of period | 20,699,000 | 0 | 0 | 0 | 17,456,000 | 1,000 | 0 | 0 | 10,402,000 | 0 | 0 | 0 | 12,595,000 | 0 | 0 | 0 | 25,172,000 | 0 | 0 |
cash, cash equivalents and restricted cash - end of period | 18,323,000 | -9,683,000 | -10,723,000 | 12,355,000 | 28,750,000 | 25,000 | -7,725,000 | -8,200,000 | 33,356,000 | -166,000 | 1,055,000 | -2,259,000 | 11,773,000 | 2,872,000 | -15,092,000 | -128,000 | 24,943,000 | -43,667,000 | 26,547,000 |
supplemental disclosure of cash flow information: | |||||||||||||||||||
operating cash flows from operating leases | 980,000 | 684,000 | 560,000 | 689,000 | 694,000 | 521,000 | 505,000 | 580,000 | 548,000 | 550,000 | 559,000 | 561,000 | 546,000 | 669,000 | 495,000 | 524,000 | 499,000 | 337,000 | 334,000 |
cash paid for income taxes | -12,000 | 0 | 67,000 | 3,000 | -2,000 | 2,000 | -4,000 | 0 | 0 | 0 | 1,000 | 5,000 | |||||||
non-cash investing and financing activities: | |||||||||||||||||||
acquisition of property and equipment included in accounts payable and accrued expenses and accrued liabilities | 170,000 | -115,000 | 46,000 | 204,000 | |||||||||||||||
amortization of debt issuance costs and premium | 0 | 4,000 | 142,000 | 141,000 | 144,000 | 143,000 | 135,000 | 130,000 | 132,000 | 132,000 | |||||||||
loss on extinguishment of debt | 0 | 1,407,000 | |||||||||||||||||
purchase of property and equipment | -847,000 | -1,103,000 | -1,523,000 | -1,967,000 | -1,591,000 | -653,000 | -1,823,000 | -747,000 | -362,000 | -580,000 | -1,081,000 | -370,000 | |||||||
maturity of short-term investments | 55,000,000 | 69,000,000 | 45,000,000 | 74,000,000 | 50,000,000 | 90,000,000 | 55,000,000 | 60,000,000 | 45,000,000 | 75,000,000 | 45,000,000 | 90,000,000 | |||||||
proceeds from term loan | 0 | 0 | 0 | 0 | |||||||||||||||
repayment of term loan | 0 | -20,000,000 | |||||||||||||||||
proceeds from issuance of common stock from public offering | 0 | 0 | 0 | 0 | 0 | 54,050,000 | |||||||||||||
proceeds from issuance of common stock from at-the-market offerings | |||||||||||||||||||
payments of deferred offering costs | 0 | -391,000 | 25,000 | -45,000 | -372,000 | -230,000 | -292,000 | 0 | |||||||||||
payments of debt issuance costs | -11,000 | -999,000 | -1,000 | -2,000 | -8,000 | -2,000 | |||||||||||||
cash paid for interest on term loan | 0 | 224,000 | 1,896,000 | 1,344,000 | 1,214,000 | 1,121,000 | 979,000 | 925,000 | 945,000 | 946,000 | |||||||||
right-of-use assets obtained in exchange for lease obligations: | |||||||||||||||||||
operating lease | 956,000 | 0 | 38,000 | 0 | 0 | 1,003,000 | 87,000 | 23,000 | |||||||||||
lease obligations recorded for right-of-use assets: | |||||||||||||||||||
acquisition of property and equipment included in accounts payable and accrued expenses and other current liabilities | 152,000 | 164,000 | -114,000 | 343,000 | 71,000 | -197,000 | 149,000 | 259,000 | 148,000 | -87,000 | 41,000 | 197,000 | -108,000 | 62,000 | |||||
deferred offering and financing costs included in accounts payable and accrued liabilities | 167,000 | 225,000 | |||||||||||||||||
reclassification of deferred financing costs | 0 | 1,536,000 | 90,000 | 2,375,000 | -1,020,000 | -55,000 | |||||||||||||
cash paid for interest on financing leases | 5,000 | 5,000 | 5,000 | 6,000 | 5,000 | 4,000 | 1,000 | 3,000 | 4,000 | 6,000 | 9,000 | 0 | 3,000 | 1,000 | 1,000 | ||||
finance lease | 0 | 0 | 10,000 | 9,000 | 0 | 23,000 | 96,000 | 192,000 | |||||||||||
net cash provided (used in) by investing activities | 24,274,000 | ||||||||||||||||||
proceeds from issuance of common stock for at-the-market offerings | 1,000 | 11,937,000 | 19,394,000 | 11,102,000 | |||||||||||||||
net decrease in cash, cash equivalents and restricted cash | -166,000 | 1,055,000 | -2,259,000 | -822,000 | |||||||||||||||
deferred offering costs included in accounts payable and accrued liabilities | -14,000 | -28,000 | -279,000 | 466,000 | -217,000 | ||||||||||||||
proceeds from exercise of stock options | 761,000 | 308,000 | 176,000 | 46,000 | |||||||||||||||
cash paid for amounts included in the measurement of lease liabilities: | |||||||||||||||||||
change in fair value of warrants | 0 | -1,503,000 | |||||||||||||||||
gain on expiration of warrant | 0 | 0 | |||||||||||||||||
proceeds from exercise of preferred stock warrants | 0 | ||||||||||||||||||
proceeds from exercise of stock options and issuance of common stock under the employee stock purchase plan | |||||||||||||||||||
proceeds from initial public offering, net of underwriting discounts and commissions and offering costs | 0 | ||||||||||||||||||
proceeds from issuance of common stock in at-the-market offerings | |||||||||||||||||||
change in notes receivables for redeemable common stock issued | 0 | ||||||||||||||||||
payment-in-kind interest income added to principal of notes receivable | 0 | 2,000 | |||||||||||||||||
reclassification from warrant liability to additional paid-in capital for warrants exercised | 0 | ||||||||||||||||||
reclassification of 4,093,995 shares of redeemable common stock to 4,093,995 shares of common stock | 0 | 0 | |||||||||||||||||
reclassification of redeemable common stock options to common stock options | 0 | 0 | |||||||||||||||||
conversion of preferred stock to common stock upon initial public offering | 0 | ||||||||||||||||||
deferred offering costs reclassified to additional paid in capital | |||||||||||||||||||
deferred offering costs included in accrued expenses | |||||||||||||||||||
net income | -15,734,000 | -12,672,000 | |||||||||||||||||
adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||||||
gain on sale of equipment | |||||||||||||||||||
proceeds from sale of equipment | |||||||||||||||||||
purchase of short-term investments | |||||||||||||||||||
accretion to redemption value of redeemable stock and stock options | |||||||||||||||||||
deferred initial public offering costs recorded to additional paid in capital | |||||||||||||||||||
proceeds from maturities of short-term investments | |||||||||||||||||||
benefit from excess and obsolete inventory | |||||||||||||||||||
change in notes receivable for redeemable common stock issued |